PARP3 and neoplasm: The effect of ME0328 had previously been studied in TNBC, enabling greater sensitization of these tumor cells to the alkaloid vinorelbine used in the treatment of metastatic breast cancer, increasing apoptosis and cell cycle arrest, vinorelbine-induced microtubule destabilization, and greater inhibition of PARP3 [58] (Figure 2).